Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study.
about
Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African AmericansIs there a role for body mass index in the assessment of prostate cancer risk on biopsy?Serum prostate specific antigen changes in cynomolgus monkeys (Macaca fascicularis) on a high sugar high fat diet.Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer.A Review on the Clinical Utility of PSA in Cancer ProstateBody mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy?Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohortHypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.Screening for prostate cancer: an updated review.The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.Association between obesity, prostate-specific antigen level and prostate-specific antigen density in men with a negative prostate biopsy.
P2860
Q34300064-36C7AF46-5D2C-4005-809E-9ECBF74AD350Q34325137-EF47FA39-B6CD-4FF8-94D5-6613EA7AF451Q35250119-CE541637-03E1-45C5-A5CC-F02394BCF189Q35292828-B54BA525-EA1A-4533-8C14-51401CBFBE23Q36084063-047B34C8-CD7D-44DF-8D1C-588E7E0B8CB9Q36791463-EA4C018D-B3C9-496E-9FF8-A7CFA35D1243Q37060574-E86D013B-9DA4-416F-9F33-4524957E1455Q37343281-7964B4A6-B2E5-45A6-B7B9-FC3933EE14AAQ37385840-733770C4-8BFF-4280-B141-D2D15619EBDAQ38000089-2C7BF76B-AD54-476E-AA9D-EEF8D4EC5167Q38069188-72E03C26-A644-4AAA-B1C9-EC206F49DE93Q40052942-ED4F5B73-3031-4036-8A49-12369493AD60Q40185822-56C14BDC-E48F-4CBF-B471-206CBB3411C6Q40888600-0FFAA899-5D42-47FA-AE6F-43FC8F1771B9Q50881517-886A5753-41BC-49AB-8A7B-21414F7DE7D4Q51740882-FB684443-9890-493F-8DCF-73A2B4BDD996
P2860
Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Body composition and serum pro ...... from Flint Men's Health Study.
@ast
Body composition and serum pro ...... from Flint Men's Health Study.
@en
type
label
Body composition and serum pro ...... from Flint Men's Health Study.
@ast
Body composition and serum pro ...... from Flint Men's Health Study.
@en
prefLabel
Body composition and serum pro ...... from Flint Men's Health Study.
@ast
Body composition and serum pro ...... from Flint Men's Health Study.
@en
P2093
P2860
P1433
P1476
Body composition and serum pro ...... from Flint Men's Health Study.
@en
P2093
Bronwen Halstead-Nussloch
David Werny
Gary J Faerber
Hal Morgenstern
Jennifer L Beebe-Dimmer
Kathleen A Cooney
Kirk Wojno
P2860
P304
P356
10.1016/J.UROLOGY.2007.11.049
P407
P577
2008-03-04T00:00:00Z